These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 29309514
21. A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80. Zhu Y, Xu J, Zhang X, Ke Y, Fu G, Guo Q. BMC Geriatr; 2021 Oct 12; 21(1):544. PubMed ID: 34641807 [Abstract] [Full Text] [Related]
22. Serum follicle stimulating hormone and estradiol in peri/postmenopausal women attending Siriraj Menopause Clinic: a retrospective study. Angsuwathana S, Tanmahasamut P, Rattanachaiyanont M, Dangrat C, Techatrisak K, Indhavivadhana S, Leerasiri P. J Med Assoc Thai; 2006 Aug 12; 89(8):1101-8. PubMed ID: 17048416 [Abstract] [Full Text] [Related]
23. Higher level of circulating estradiol is associated with lower frequency of cognitive impairment in Southeast China. Hu J, Chu K, Song Y, Chatooah ND, Ying Q, Ma L, Zhou J, Qu F, Zhou J. Gynecol Endocrinol; 2017 Nov 12; 33(11):840-844. PubMed ID: 28466687 [Abstract] [Full Text] [Related]
25. The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause. Yoldemir T, Erenus M, Durmusoglu F. Gynecol Endocrinol; 2012 Nov 12; 28(11):884-8. PubMed ID: 22731753 [Abstract] [Full Text] [Related]
27. Serum parathyroid hormone is associated with carotid intima-media thickness in postmenopausal women. Choi HS, Kim SH, Rhee Y, Cho MA, Lee EJ, Lim SK. Int J Clin Pract; 2008 Sep 12; 62(9):1352-7. PubMed ID: 18657200 [Abstract] [Full Text] [Related]
28. Follicle-stimulating hormone associates with prediabetes and diabetes in postmenopausal women. Wang N, Kuang L, Han B, Li Q, Chen Y, Zhu C, Chen Y, Xia F, Cang Z, Zhu C, Lu M, Meng Y, Guo H, Chen C, Lin D, Lu Y. Acta Diabetol; 2016 Apr 12; 53(2):227-36. PubMed ID: 25959422 [Abstract] [Full Text] [Related]
31. A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women. Ryan J, Burger HG, Szoeke C, Lehert P, Ancelin ML, Henderson VW, Dennerstein L. Menopause; 2009 Apr 12; 16(3):509-17. PubMed ID: 19169164 [Abstract] [Full Text] [Related]
32. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A. Breast Cancer Res Treat; 2008 Mar 12; 108(1):57-67. PubMed ID: 17468953 [Abstract] [Full Text] [Related]
33. Accumulation of Depressive Symptoms and Carotid Intima-Media Thickness: the Cardiovascular Risk in Young Finns Study. Keltikangas-Järvinen L, Savelieva K, Josefsson K, Elovainio M, Pulkki-Råback L, Juonala M, Raitakari OT, Hintsanen M. Ann Behav Med; 2017 Aug 12; 51(4):620-628. PubMed ID: 28251578 [Abstract] [Full Text] [Related]
34. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Ouyang P, Vaidya D, Dobs A, Golden SH, Szklo M, Heckbert SR, Kopp P, Gapstur SM. Atherosclerosis; 2009 May 12; 204(1):255-61. PubMed ID: 18849030 [Abstract] [Full Text] [Related]
35. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Reyes FI, Winter JS, Faiman C. Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845 [Abstract] [Full Text] [Related]